Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: result (Q38440248)
Jump to navigation
Jump to search
scientific article published on 02 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: result |
scientific article published on 02 December 2013 |
Statements
1 reference
Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: result (English)
1 reference
Faiez Zannad
1 reference
Bertram Pitt
1 reference
Patrick Rossignol
1 reference
Karl Swedberg
1 reference
Dirk J van Veldhuisen
1 reference
Henry Krum
1 reference
John J V McMurray
1 reference
Harry Shi
1 reference
George Bakris
1 reference
Daniela Dobre
1 reference
Michael Messig
1 reference
John Vincent
1 reference
2 December 2013
1 reference
1 reference
Identifiers
1 reference